IT1175260B - Agente anti ipercolesterolemico e procedimento per la sua preparazione - Google Patents

Agente anti ipercolesterolemico e procedimento per la sua preparazione

Info

Publication number
IT1175260B
IT1175260B IT67262/80A IT6726280A IT1175260B IT 1175260 B IT1175260 B IT 1175260B IT 67262/80 A IT67262/80 A IT 67262/80A IT 6726280 A IT6726280 A IT 6726280A IT 1175260 B IT1175260 B IT 1175260B
Authority
IT
Italy
Prior art keywords
procedure
preparation
hypercholesterolemic agent
anti hypercholesterolemic
agent
Prior art date
Application number
IT67262/80A
Other languages
English (en)
Other versions
IT8067262A0 (it
Inventor
Endo Akira
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IT8067262A0 publication Critical patent/IT8067262A0/it
Application granted granted Critical
Publication of IT1175260B publication Critical patent/IT1175260B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
IT67262/80A 1979-02-20 1980-02-20 Agente anti ipercolesterolemico e procedimento per la sua preparazione IT1175260B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (2)

Publication Number Publication Date
IT8067262A0 IT8067262A0 (it) 1980-02-20
IT1175260B true IT1175260B (it) 1987-07-01

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67262/80A IT1175260B (it) 1979-02-20 1980-02-20 Agente anti ipercolesterolemico e procedimento per la sua preparazione

Country Status (27)

Country Link
JP (1) JPS5925599B2 (it)
KR (1) KR830002801B1 (it)
AT (1) AT373915B (it)
AU (1) AU532626B2 (it)
BE (1) BE881825A (it)
CA (1) CA1129794A (it)
CH (1) CH645890A5 (it)
DD (1) DD154494A5 (it)
DE (2) DE3051175C2 (it)
DK (2) DK149095C (it)
ES (1) ES488796A0 (it)
FI (1) FI66427C (it)
FR (1) FR2449685B1 (it)
GB (1) GB2046737B (it)
HU (1) HU182069B (it)
IE (1) IE49743B1 (it)
IT (1) IT1175260B (it)
MX (1) MX6314E (it)
NL (1) NL191540C (it)
NO (1) NO153974C (it)
NZ (1) NZ192919A (it)
PH (1) PH15145A (it)
PL (1) PL124304B1 (it)
SE (1) SE453301B (it)
SG (1) SG6784G (it)
SU (2) SU1158048A3 (it)
ZA (1) ZA80962B (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 ＨＭＧ−ＣｏＡレダクターゼ阻害物質としてのテトラリン誘導体
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
UA73074C2 (en) 1998-03-20 2005-06-15 Method of controlled fermentation for production of lovastatin as hydroxy-acid
CZ20022779A3 (cs) 2000-02-24 2003-02-12 Biogal Gyogyszergyar Rt. Způsob purifikace fermentačního bujónu
WO2001066538A1 (en) 2000-03-03 2001-09-13 Biogal Gyogyszergyar Rt. A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (it) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
ATE356554T1 (de) * 2001-02-09 2007-04-15 Unilever Nv Nahrungsmittel enthaltend sojaprotein und statin
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
SI2373609T1 (sl) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (it) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS5925599B2 (ja) 1984-06-19
PH15145A (en) 1982-08-24
AU5567380A (en) 1980-08-28
KR830002801B1 (ko) 1983-12-16
DK73080A (da) 1980-08-21
ATA92980A (de) 1983-07-15
PL222120A1 (it) 1980-10-20
IE49743B1 (en) 1985-12-11
NO153974C (no) 1986-06-25
SE8001339L (sv) 1980-08-21
FI800506A (fi) 1980-08-21
SE453301B (sv) 1988-01-25
ZA80962B (en) 1981-03-25
DE3006216A1 (de) 1980-09-04
IT8067262A0 (it) 1980-02-20
ES8103171A1 (es) 1981-02-16
PL124304B1 (en) 1983-01-31
GB2046737A (en) 1980-11-19
SG6784G (en) 1985-02-08
CH645890A5 (de) 1984-10-31
NL8001041A (nl) 1980-08-22
FR2449685B1 (fr) 1985-06-28
NO800451L (no) 1980-08-21
NL191540B (nl) 1995-05-01
AT373915B (de) 1984-03-12
DK21889A (da) 1989-01-18
GB2046737B (en) 1983-01-12
NO153974B (no) 1986-03-17
DK149095C (da) 1986-06-16
DK21889D0 (da) 1989-01-18
ES488796A0 (es) 1981-02-16
CA1129794A (en) 1982-08-17
DK149095B (da) 1986-01-20
IE800321L (en) 1980-08-20
KR830002030A (ko) 1983-05-21
JPS55111790A (en) 1980-08-28
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
DE3006216C2 (de) 1985-10-31
BE881825A (fr) 1980-08-20
SU1158048A3 (ru) 1985-05-23
MX6314E (es) 1985-04-01
NZ192919A (en) 1984-07-06
DE3051175C2 (it) 1989-12-21
SU969702A1 (ru) 1982-10-30
HU182069B (en) 1983-12-28
FI66427B (fi) 1984-06-29
DD154494A5 (de) 1982-03-24
AU532626B2 (en) 1983-10-06
NL191540C (nl) 1995-09-04

Similar Documents

Publication Publication Date Title
IT1175260B (it) Agente anti ipercolesterolemico e procedimento per la sua preparazione
IT1129802B (it) Agente antitumorale
MX5676E (es) Procedimiento mejorado para la preparacion de cicloalcanoles y cicloalcanonas
IT1084178B (it) Poli-di carbo-monofluoruro e procedimento per la sua preparazione
IT1119922B (it) Sostanza anti tumorale e procedimento per la sua preparazione
IT1130944B (it) Agente disaprettante e processo per la sua preparazione
BR8004481A (pt) Composicoes de aclaradores oticos,sua obtencao e utilizacao
IT1142029B (it) Preparato cosmetico e procedimento per la sua preparazione
BR8005664A (pt) Esteres quaternarios de hidroxialquilamidoaminas,processos para sua preparacao e sua aplicacao
AR220383A1 (es) Procedimiento para la preparacion de 2,3,5,6-tetracloropiridina y pentacloropiridina
IT1141591B (it) Prodotto disinfestante e procedimento per la sua preparazione
IT8048889A0 (it) Composti perfluoroalchilici e procedimento per prepararli
IT1146125B (it) Manica filtrante e procedimento per la sua fabbricazione
ES488513A0 (es) Procedimiento para la preparacion de fenoxi y tiofenoxinitrilos.
ES495814A0 (es) Procedimiento de desempolvado de particulas
ES480979A0 (es) Procedimiento de pre-paracion de compuestos opacificantes para radiografia y similares.
IT1165040B (it) Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
IT1118225B (it) Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
SE7811593L (sv) 2,4-diamino-5-bensylpyrimidiner och forfarande for framstellning derav
IT7830608A0 (it) Composizione polistirolica autoestinguente e procedimento per la sua preparazione.
IT1141632B (it) Antibiotico marcrolidico e procedimento per la sua preparazione
IT1129501B (it) Procedimento e dispositivo per la preparazione per precipitazioni-flottazione di rottami di accumulatori
IT8224456A0 (it) Prostacicline e procedimento per laloro preparazione
IT8067127A0 (it) Supposta farmaceutica e procedimento per la sua preparazione
IT1163674B (it) 1,6-dimesil-3,4-dimetil-d-mannitolo e procedimento per la sua preparazione

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227